Xealth Inc. operates a digital health prescribing platform designed to enhance the integration and management of digital health tools within healthcare systems. Founded in 2016 and based in Seattle, Washington, the platform allows clinicians to prescribe and monitor digital health solutions directly from electronic health records (EHR) workflows. This capability enables care teams to identify appropriate digital tools for patients, which can be sent to their smartphones or desktops for easy access. Additionally, Xealth supports patient education and offers services such as ride shares and food delivery. The platform facilitates monitoring of patient engagement, providing insights into the effectiveness of these digital interventions. Originally spun out of Providence St. Joseph Health in 2017, Xealth has attracted investments from various healthcare-focused entities, including McKesson Ventures and Novartis.
CarepathRx is a provider of enterprise management systems tailored for the healthcare industry, focusing on transforming hospital pharmacies into revenue-generating assets. The company offers comprehensive pharmacy services, including specialty medications, infusion therapy, and continuous home care solutions, addressing a wide range of prescription needs. By leveraging advanced technology and a suite of services, CarepathRx aims to optimize pharmacy performance across healthcare organizations, ensuring consistent and efficient service delivery.
Abridge AI Inc. is a developer of a healthcare mobile application that focuses on enhancing understanding during medical conversations. Founded in 2018 and headquartered in Pittsburgh, Pennsylvania, Abridge's application utilizes machine learning to record and summarize audio from medical discussions, helping users identify diagnoses, medications, and treatments. This technology aims to provide clarity and context, enabling individuals to better follow through with healthcare recommendations and stay informed about their health. By highlighting essential medical terms, Abridge empowers users to actively engage in their healthcare journeys, whether in clinical settings or at home.
Abridge AI Inc. is a developer of a healthcare mobile application that focuses on enhancing understanding during medical conversations. Founded in 2018 and headquartered in Pittsburgh, Pennsylvania, Abridge's application utilizes machine learning to record and summarize audio from medical discussions, helping users identify diagnoses, medications, and treatments. This technology aims to provide clarity and context, enabling individuals to better follow through with healthcare recommendations and stay informed about their health. By highlighting essential medical terms, Abridge empowers users to actively engage in their healthcare journeys, whether in clinical settings or at home.
Prodigo Solutions, launched by healthcare supply chain professionals, is focused on driving real savings in the healthcare supply chain. Prodigo's suite of managed services and solutions are proven to drive contract compliance, automation, data quality and user adoption. Prodigo's suite of SaaS solutions includes ProdigoBuyer (web-based requisitioning with workflow), ProdigoMarketplace (content management and punchout audit) and ProdigoXchange (B2B transaction services like EDI and fax/email purchase orders).
Werewolf Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative cancer immunotherapies. Founded in 2017, the company is advancing a pipeline of therapeutic candidates designed to stimulate the immune system specifically within the tumor microenvironment. Utilizing its proprietary PREDATOR platform, Werewolf Therapeutics engineers conditionally activated molecules known as INDUKINE, which remain inactive in peripheral tissues but activate selectively in the presence of tumors. This targeted approach aims to enhance both adaptive and innate immune responses, addressing limitations associated with traditional proinflammatory therapies. Through its research and development efforts, Werewolf Therapeutics is committed to transforming cancer treatment.
RxAnte Inc. is a healthcare analytics company focused on improving medication adherence through the use of predictive analytics. Founded in 2008 and based in Portland, Maine, RxAnte provides an innovative platform that transforms claims data into actionable insights, enabling healthcare organizations to identify patients who are most likely to benefit from adherence interventions. The company's solutions allow for the targeting, management, and evaluation of adherence support initiatives, ultimately enhancing medication prescribing and adherence while improving clinical quality and reducing overall healthcare costs. As of 2014, RxAnte operates as a subsidiary of Millennium Laboratories, Inc.
Xealth Inc. operates a digital health prescribing platform designed to enhance the integration and management of digital health tools within healthcare systems. Founded in 2016 and based in Seattle, Washington, the platform allows clinicians to prescribe and monitor digital health solutions directly from electronic health records (EHR) workflows. This capability enables care teams to identify appropriate digital tools for patients, which can be sent to their smartphones or desktops for easy access. Additionally, Xealth supports patient education and offers services such as ride shares and food delivery. The platform facilitates monitoring of patient engagement, providing insights into the effectiveness of these digital interventions. Originally spun out of Providence St. Joseph Health in 2017, Xealth has attracted investments from various healthcare-focused entities, including McKesson Ventures and Novartis.
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.
Prodigo Solutions, launched by healthcare supply chain professionals, is focused on driving real savings in the healthcare supply chain. Prodigo's suite of managed services and solutions are proven to drive contract compliance, automation, data quality and user adoption. Prodigo's suite of SaaS solutions includes ProdigoBuyer (web-based requisitioning with workflow), ProdigoMarketplace (content management and punchout audit) and ProdigoXchange (B2B transaction services like EDI and fax/email purchase orders).
Globin Solutions, Inc. is a biotechnology company based in Pittsburgh, Pennsylvania, that was incorporated in 2017. It focuses on the research and development of a rapidly acting antidote for carbon monoxide poisoning, a prevalent type of poisoning in humans. As a pre-clinical stage biopharmaceutical firm, Globin Solutions aims to advance its lead compound through rigorous preclinical testing, with the intention of obtaining regulatory approval for clinical trials. The company collaborates with experts in globin chemistry and protein engineering, particularly through partnerships with the University of Pittsburgh, to enhance its pipeline of therapeutic agents not only for carbon monoxide poisoning but potentially for other medical indications as well.
Xealth Inc. operates a digital health prescribing platform designed to enhance the integration and management of digital health tools within healthcare systems. Founded in 2016 and based in Seattle, Washington, the platform allows clinicians to prescribe and monitor digital health solutions directly from electronic health records (EHR) workflows. This capability enables care teams to identify appropriate digital tools for patients, which can be sent to their smartphones or desktops for easy access. Additionally, Xealth supports patient education and offers services such as ride shares and food delivery. The platform facilitates monitoring of patient engagement, providing insights into the effectiveness of these digital interventions. Originally spun out of Providence St. Joseph Health in 2017, Xealth has attracted investments from various healthcare-focused entities, including McKesson Ventures and Novartis.
ALung Technologies, Inc. is a medical device company based in Pittsburgh, Pennsylvania, specializing in the development and manufacturing of devices for treating acute respiratory failure. The company's primary product, the Hemolung Respiratory Assist System, serves as a dialysis-like alternative to mechanical ventilation by removing carbon dioxide and delivering oxygen directly into the blood. This technology allows patients' lungs to rest and recover while avoiding the need for intubation and enabling protective ventilation. In addition to the Hemolung system, ALung Technologies also develops the Hattler Catheter, which facilitates extracorporeal gas exchange by circulating blood through a small catheter inserted into the central venous bloodstream. Founded in 1997, the company focuses on innovative solutions for both acute and chronic respiratory disorders.
UPMC Susquehanna is an affiliate of UPMC and a northcentral Pennsylvania based health system that includes Divine Providence Hospital, Muncy Valley Hospital, Soldiers & Sailors Memorial Hospital and Williamsport Regional Medical Center. Serving patients from an 11-county region, UPMC Susquehanna has been recognized at the national and state levels for quality of care. This regional provider offers a wide array of services that include cancer care, heart and vascular care/heart surgery, neurosciences including neurosurgery, orthopedics, urology, OB/GYN, gastrointestinal services, behavioral health, physical rehabilitation, home care, long term care, assisted living and paramedic/ambulance services.
RxAnte Inc. is a healthcare analytics company focused on improving medication adherence through the use of predictive analytics. Founded in 2008 and based in Portland, Maine, RxAnte provides an innovative platform that transforms claims data into actionable insights, enabling healthcare organizations to identify patients who are most likely to benefit from adherence interventions. The company's solutions allow for the targeting, management, and evaluation of adherence support initiatives, ultimately enhancing medication prescribing and adherence while improving clinical quality and reducing overall healthcare costs. As of 2014, RxAnte operates as a subsidiary of Millennium Laboratories, Inc.
Cernostics, Inc. is a diagnostics company based in Pittsburgh, Pennsylvania, specializing in cancer diagnostics and prognostics through a tissue systems biology approach. Founded in 2008, Cernostics develops the TissueCypher Barrett’s esophagus assay, which utilizes whole slide digital imaging technology to assess the risk for patients with Barrett’s esophagus, thereby reducing uncertainty in treatment decisions for gastroenterologists. The company's patent-protected TissueCypher platform analyzes whole slide digital images using multiplexed fluorescence, enhancing the accuracy of traditional tissue diagnostics by evaluating tumors as complex systems comprised of multiple cell types. Additionally, Cernostics operates a high-complexity clinical reference laboratory that supports biomarker discovery, validation, and clinical trial efforts, ultimately aiming to improve patient outcomes and reduce healthcare costs. The company has established a strategic collaboration with Deciphex Limited to further its capabilities in spatial biology and AI-driven image analytics.
Fabric Genomics is making genomics-driven precision medicine a reality. We provide clinical decision support software that enables clinical labs, hospital systems and country-sequencing programs to gain actionable genomic insights, resulting in faster and more accurate diagnoses and reduced turnaround time. Fabric’s end-to-end genomic analysis platform incorporates proven AI algorithms, and has applications in both hereditary disease and oncology. Headquartered in Oakland, California, Fabric Genomics was founded by industry veterans and innovators with a deep understanding of bioinformatics, large-scale genomics and clinical diagnostics.
MedCPU Inc. develops real-time enterprise decision support software aimed at enhancing clinical care in hospitals across the United States. Founded in 2008 and based in New York, the company offers the medCPU Advisor platform, which integrates patient profiles derived from both structured and unstructured data. Its innovative Advisor Button technology captures and analyzes clinical information from clinicians’ free-text notes, dictations, and structured documentation entered into electronic medical records (EMRs). This analysis is conducted against an extensive library of medical content, allowing the platform to generate precise, real-time prompts for care consideration, as well as providing clinical and compliance guidance. MedCPU's focus is on improving decision-making processes in healthcare settings through advanced data integration and analysis.
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.
Finding emotional well-being during life’s twists and turns isn’t easy. Accessing care is at best expensive, and at worst completely out of reach. And that’s where Lantern comes in. Founded in 2012 in San Francisco, they’re a team of researchers, technologists, and clinicians translating clinical research and expertise into simple, effective web and mobile programs based in cognitive behavioral therapy. They’re not about unrealistic promises or get-happy-quick schemes. They’re about removing the stigma and barriers that prevent people from strengthening their emotional selves, offering a holistic approach to making every day better. They envision a world in which people think differently about their mental health–where they feel empowered to take a simple step toward self-improvement. They’re on a mission to make this happen, and they hope you’ll join us.
Health Fidelity, Inc. specializes in enhancing risk adjustment processes for health plans participating in Medicare Advantage, the Affordable Care Act, Medicaid, and Accountable Care Organizations. Founded in 2011 and headquartered in San Mateo, California, the company utilizes advanced natural language processing technology to analyze clinical documentation and uncover hidden risk factors within medical charts. This automated approach transforms the manual aspects of risk adjustment into a streamlined workflow, providing organizations with clear visibility and control over their risk management processes. Health Fidelity also offers solutions such as Risk Analytics, which optimizes risk adjustment performance and identifies care gaps, and HF360 Compliance, aimed at ensuring accurate results and minimizing audit risks. As a subsidiary of the University of Pittsburgh Medical Center, Health Fidelity is committed to improving revenue capture and enabling more effective care planning for its partners.
Prodigo Solutions, launched by healthcare supply chain professionals, is focused on driving real savings in the healthcare supply chain. Prodigo's suite of managed services and solutions are proven to drive contract compliance, automation, data quality and user adoption. Prodigo's suite of SaaS solutions includes ProdigoBuyer (web-based requisitioning with workflow), ProdigoMarketplace (content management and punchout audit) and ProdigoXchange (B2B transaction services like EDI and fax/email purchase orders).
Evolent Health is a population health management services organization that aids health systems and physician organizations in transitioning to value-based care. The company provides an integrated platform that combines technology and resources to support care transformation objectives. Evolent Health specializes in offering services in specialty care management for oncology, cardiology, and musculoskeletal markets, as well as holistic total cost of care management. Additionally, it delivers administrative services designed to streamline health plan operations and enhance value-based business infrastructure. Through its comprehensive solutions, Evolent Health aims to improve healthcare delivery and payment systems while promoting effective population health management.
dbMotion is a developer of a health information exchange platform focused on creating connected healthcare communities. Its software facilitates the development of secure virtual patient records by integrating patient information from various care providers and organizations without the need for data centralization or the replacement of existing systems. This interoperability enables healthcare organizations to share clinical information securely, regardless of data format or geographical location. By effectively connecting disparate information assets, dbMotion aims to enhance the quality, safety, and efficiency of patient care, ultimately transforming healthcare delivery through improved collaboration among care providers.
dbMotion is a developer of a health information exchange platform focused on creating connected healthcare communities. Its software facilitates the development of secure virtual patient records by integrating patient information from various care providers and organizations without the need for data centralization or the replacement of existing systems. This interoperability enables healthcare organizations to share clinical information securely, regardless of data format or geographical location. By effectively connecting disparate information assets, dbMotion aims to enhance the quality, safety, and efficiency of patient care, ultimately transforming healthcare delivery through improved collaboration among care providers.
BodyMedia, founded in 1999 and based in Pittsburgh, PA, specializes in wearable body monitoring devices that gather physiological data to enhance health, wellness, and fitness. The company offers a range of continuous on-body monitors that utilize proprietary technology validated for clinical accuracy. These devices serve both consumers and health professionals, facilitating behavioral adjustments aimed at weight management and active living—critical factors in addressing serious health issues. BodyMedia's products include a calorie management system that tracks calories burned against those consumed, alongside body monitoring systems that record various physiological metrics analyzed through its SenseWear software. The company has contributed significantly to health research, participating in over 100 clinical studies related to obesity, diabetes, and other medical conditions, thereby creating one of the largest databases of human physiological information.
Renal Solutions is focused on the development of dialysis products and services. Renal Solutions was acquired by Fresenius Medical Care in November 2007. Renal Solutions was founded in 2000 and is based in Warrendale, Pennsylvania.
BodyMedia, founded in 1999 and based in Pittsburgh, PA, specializes in wearable body monitoring devices that gather physiological data to enhance health, wellness, and fitness. The company offers a range of continuous on-body monitors that utilize proprietary technology validated for clinical accuracy. These devices serve both consumers and health professionals, facilitating behavioral adjustments aimed at weight management and active living—critical factors in addressing serious health issues. BodyMedia's products include a calorie management system that tracks calories burned against those consumed, alongside body monitoring systems that record various physiological metrics analyzed through its SenseWear software. The company has contributed significantly to health research, participating in over 100 clinical studies related to obesity, diabetes, and other medical conditions, thereby creating one of the largest databases of human physiological information.